Oncoustics

Oncoustics, founded in 2018 and headquartered in Canada, is innovating the health care industry by transforming low-cost, point-of-care ultrasound systems into sophisticated surveillance, diagnostic, and monitoring tools. This capability plays a crucial role in preventive care and early intervention, making them a unique player in the AI, Biotechnology, Health Care, and Medical Devices sectors.

Their recent financing milestone was a Seed Round investment on 28 February 2023, showing confidence from investors like UCeed. This backing underscores the company’s potential to address pressing needs in medical diagnostics with an accessible and technologically advanced solution.

As they continue to innovate, Oncoustics has positioned itself as a compelling opportunity for investors interested in companies that are at the intersection of cutting-edge technology and crucial health care advancements.